Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacidophilin with Vonoprazan and Amoxicillin for H. pylori Eradication
NCT05749081Phase 4Active, not recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- May 2023
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Helicobacter pylori infection comparing Lacidophilin + VA Dual Therapy with Placebo + VA Dual Therapy (2 arms). Primary endpoint: Efficacy of Treatment. Started May 2023; status: active, not recruiting.
02
Drugs
lactobacillus acidophilus
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05749081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05749081.